These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Catalytic antibodies for complex reactions: hapten design and the importance of screening for catalysis in the generation of catalytic antibodies for the NDA/CN reaction. DeSilva BS; Orosz G; Egodage KL; Carlson RG; Schowen RL; Wilson GS Appl Biochem Biotechnol; 2000; 83(1-3):195-206; discussion 206-8, 297-313. PubMed ID: 10826960 [TBL] [Abstract][Full Text] [Related]
7. Catalytic antibodies that hydrolyze (-)-cocaine obtained by a high-throughput procedure. Cashman JR; Berkman CE; Underiner GE J Pharmacol Exp Ther; 2000 Jun; 293(3):952-61. PubMed ID: 10869397 [TBL] [Abstract][Full Text] [Related]
8. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination. Wenthur CJ; Cai X; Ellis BA; Janda KD Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828 [TBL] [Abstract][Full Text] [Related]
9. An improved rapid method for selecting monoclonal antibodies with high catalytic activities. Yuan YR; Yang BH; Ji YY J Protein Chem; 1997 Nov; 16(8):733-8. PubMed ID: 9365921 [TBL] [Abstract][Full Text] [Related]
12. A comparison of flexible and constrained haptens in eliciting antibody catalysts for paraoxon hydrolysis. Spivak DA; Hoffman TZ; Moore AH; Taylor MJ; Janda KD Bioorg Med Chem; 1999 Jun; 7(6):1145-50. PubMed ID: 10428386 [TBL] [Abstract][Full Text] [Related]
13. The immunological evolution of catalysis. Patten PA; Gray NS; Yang PL; Marks CB; Wedemayer GJ; Boniface JJ; Stevens RC; Schultz PG Science; 1996 Feb; 271(5252):1086-91. PubMed ID: 8599084 [TBL] [Abstract][Full Text] [Related]
14. A common ancestry for multiple catalytic antibodies generated against a single transition-state analog. Miyashita H; Hara T; Tanimura R; Tanaka F; Kikuchi M; Fujii I Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6045-9. PubMed ID: 8016113 [TBL] [Abstract][Full Text] [Related]
15. A new visual screening assay for catalytic antibodies with retro-aldol retro-Michael activity. Shamis M; Barbas CF; Shabat D Bioorg Med Chem Lett; 2007 Mar; 17(5):1172-5. PubMed ID: 17234408 [TBL] [Abstract][Full Text] [Related]
16. Origins and predictions of stereoselective antibody catalysis: theoretical analysis of Diels-Alder catalysis by 39A11 and its germ-line antibody. Zhang X; Deng Q; Yoo SH; Houk KN J Org Chem; 2002 Dec; 67(25):9043-53. PubMed ID: 12467427 [TBL] [Abstract][Full Text] [Related]
17. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies. Ulrich HD; Schultz PG J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442 [TBL] [Abstract][Full Text] [Related]
18. catELISA: a facile general route to catalytic antibodies. Tawfik DS; Green BS; Chap R; Sela M; Eshhar Z Proc Natl Acad Sci U S A; 1993 Jan; 90(2):373-7. PubMed ID: 7678455 [TBL] [Abstract][Full Text] [Related]
19. Probing ligand recognition in the decarboxylase antibody 21D8: implications for the catalytic mechanism. Hotta K; Wilson IA; Hilvert D Biochemistry; 2002 Jan; 41(3):772-9. PubMed ID: 11790098 [TBL] [Abstract][Full Text] [Related]